Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy
Abstract Background In clinical practice, several radiopharmaceuticals are used for PSMA-PET imaging, each with distinct biodistribution patterns. This may impact treatment decisions and outcomes, as eligibility for PSMA-directed radioligand therapy is usually assessed by comparing tumoral uptake to...
Saved in:
| Main Authors: | Jan Heilinger, Katrin Sabine Roth, Henning Weis, Antonis Fink, Jasmin Weindler, Felix Dietlein, Philipp Krapf, Klaus Schomäcker, Bernd Neumaier, Markus Dietlein, Alexander Drzezga, Carsten Kobe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-01-01
|
| Series: | EJNMMI Research |
| Online Access: | https://doi.org/10.1186/s13550-024-01190-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.
by: Eleni Gourni, et al.
Published: (2015-01-01) -
Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System
by: Zsófia Sára Mikó, et al.
Published: (2024-10-01) -
Characterizing PSMA heterogeneity in prostate cancer and identifying clinically actionable tumor associated antigens in PSMA negative cases
by: Yelin Mulati, et al.
Published: (2025-07-01) -
Optimization of PSMA-I&T radiolabeling with 177Lu
by: Luiza Mascarenhas Balieiro, et al.
Published: (2025-06-01) -
Pre- or post-chemotherapy: effect on PSMA uptake
by: Surekha Yadav, et al.
Published: (2025-04-01)